# Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever

> **NCT01500629** · EARLY_PHASE1 · COMPLETED · sponsor: **McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DEVICE:** C-1266-7
- **DEVICE:** C-1266-6 (placebo)

## Key facts

- **NCT ID:** NCT01500629
- **Lead sponsor:** McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500629, "Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01500629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*